Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. (Record no. 27243196)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01945 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517155700.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201708s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1533-4406 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1056/NEJMoa1706450 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Robson, Mark |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20170822 |
245 00 - TITLE STATEMENT | |
Title | Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The New England journal of medicine |
Date of publication, distribution, etc. | 08 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 523-533 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemotherapy, Adjuvant |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genes, BRCA1 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genes, BRCA2 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Germ-Line Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Metastasis |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phthalazines |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperazines |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Poly(ADP-ribose) Polymerase Inhibitors |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, ErbB-2 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Im, Seock-Ah |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Senkus, Elżbieta |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xu, Binghe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Domchek, Susan M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Masuda, Norikazu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Delaloge, Suzette |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Wei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tung, Nadine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Armstrong, Anne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wu, Wenting |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goessl, Carsten |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Runswick, Sarah |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Conte, Pierfranco |
773 0# - HOST ITEM ENTRY | |
Title | The New England journal of medicine |
Related parts | vol. 377 |
-- | no. 6 |
-- | p. 523-533 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMoa1706450">https://doi.org/10.1056/NEJMoa1706450</a> |
Public note | Available from publisher's website |
No items available.